In The News Posted March 6, 2019 Share Posted March 6, 2019 STOCKHOLM, March 6, 2019 /PRNewswire/ -- IRRAS AB (Nasdaq First North Premier: IRRAS), a commercial-stage medical science and technology company, today announced that its board has resolved to revise the company's financial targets. The financial targets that will apply effective today... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.